Literature DB >> 16037546

Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase.

Mouad Edderkaoui1, Peggy Hong, Eva C Vaquero, Jong K Lee, Lars Fischer, Helmut Friess, Markus W Buchler, Markus M Lerch, Stephen J Pandol, Anna S Gukovskaya.   

Abstract

The extracellular matrix (ECM) facilitates pancreatic cancer cells survival, which is of central importance for pancreatic adenocarcinoma that is highly fibrotic. Here, we show that reactive oxygen species (ROS) mediate the prosurvival effect of ECM in human pancreatic cancer cells. Fibronectin and laminin stimulated ROS production and NADPH oxidase activation in pancreatic cancer cells. Both pharmacological and molecular approaches show that fibronectin stimulated ROS production through activation of NADPH oxidase and NADPH oxidase-independent pathways and that 5-lipoxygenase (5-LO) mediates both these pathways. Analyses of the mechanisms of ROS production by ECM proteins and growth factors indicate that activation of NADPH oxidase (Nox4) is a common mechanism employed both by ECM proteins and growth factors to increase ROS in pancreatic cancer cells. We also found that Nox4 is present in human pancreatic adenocarcinoma tissues and that these tissues display membrane NADPH oxidase activity. ECM proteins and growth factors activate NADPH oxidase through different mechanisms; in contrast to ECM proteins, growth factors activate NADPH oxidase through 5-LO-independent mechanisms. Inhibition of 5-LO or NADPH oxidase with pharmacological inhibitors of these enzymes and with Nox4 or 5-LO antisense oligonucleotides markedly stimulated apoptosis in cancer cells cultured on fibronectin. Our results indicate that ROS generation via 5-LO and downstream NADPH oxidase mediates the prosurvival effect of ECM in pancreatic cancer cells. These mechanisms may play an important role in pancreatic cancer resistance to treatments and thus represent novel therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037546     DOI: 10.1152/ajpgi.00197.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  54 in total

1.  The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.

Authors:  Claudia Nitsche; Mouad Edderkaoui; Ryan M Moore; Guido Eibl; Noriyuki Kasahara; Janet Treger; Paul J Grippo; Julia Mayerle; Markus M Lerch; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells.

Authors:  Mouad Edderkaoui; Aurelia Lugea; Hongxiang Hui; Guido Eibl; Qing-Yi Lu; Aune Moro; Xuyang Lu; Gang Li; Vay-Liang Go; Stephen J Pandol
Journal:  Nutr Cancer       Date:  2013-10-15       Impact factor: 2.900

4.  Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell lines.

Authors:  Yongzhong Wu; Jiamo Lu; Smitha Antony; Agnes Juhasz; Han Liu; Guojian Jiang; Jennifer L Meitzler; Melinda Hollingshead; Diana C Haines; Donna Butcher; Krishnendu Roy; James H Doroshow
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

5.  Akt kinase mediates the prosurvival effect of smoking compounds in pancreatic ductal cells.

Authors:  Chang-Hwan Park; In-Seok Lee; Paul Grippo; Stephen J Pandol; Anna S Gukovskaya; Mouad Edderkaoui
Journal:  Pancreas       Date:  2013-05       Impact factor: 3.327

Review 6.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.

Authors:  Mouad Edderkaoui; Chintan Chheda; Badr Soufi; Fouzia Zayou; Robert W Hu; V Krishnan Ramanujan; Xinlei Pan; Laszlo G Boros; Jian Tajbakhsh; Anisha Madhav; Neil A Bhowmick; Qiang Wang; Michael Lewis; Richard Tuli; Aida Habtezion; Ramachandran Murali; Stephen J Pandol
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

8.  Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.

Authors:  Miao Wang; Mary Topalovski; Jason E Toombs; Christopher M Wright; Zachary R Moore; David A Boothman; Hiromi Yanagisawa; Huamin Wang; Agnieszka Witkiewicz; Diego H Castrillon; Rolf A Brekken
Journal:  Cancer Res       Date:  2015-11-17       Impact factor: 12.701

9.  Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4.

Authors:  Danielle T Loughlin; Carol M Artlett
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

10.  Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family.

Authors:  Izumi Ohno; Guido Eibl; Irina Odinokova; Mouad Edderkaoui; Robert D Damoiseaux; Moussa Yazbec; Ravinder Abrol; William A Goddard; Osamu Yokosuka; Stephen J Pandol; Anna S Gukovskaya
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-17       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.